Register / Log In

Hospital/Health-System Pharmacy

New SSRI approved in last quarter of 2013
FDA approved vortioxetine as oral tablets indicated for the treatment of major depressive disorder.
Same-day care, capacity key to managing flu season
Last year’s flu season brought chills to some providers; experts say planning, education are even more critical now
AAP report updates use of medications during breast-feeding
The American Academy of Pediatrics (AAP) clinical report released this week provides guidance for physicians about the use of psychotropic drugs, substance abuse treatments, narcotics, galactagogues, herbal products, and vaccines in breast-feeding women and the potential effects on the breast-feeding infant.
The few words that change everything
Some thoughts about the things that count
Long-term data reinforce safety profile of dabigatran
Results from the RELY-ABLE trial, the RE-LY extension study, support the long-term safety profile of dabigatran etexilate mesylate (Pradaxa, Boehringer Ingelheim Pharmaceuticals) 150 mg twice daily in patients with nonvalvular atrial fibrillation (NVAF), according to a study published in Circulation in mid-June.
Tennessee pharmacy board strengthens compounding rules
Less than a month after FDA warned of an outbreak following steroid injections from a compounding pharmacy there, the Tennessee Board of Pharmacy (TBOP) strengthened its oversight of compounding pharmacies.
Anticoagulant dosing in obesity should be individualized and drug-specific

FDA approves sublingual agent for treatment of opioid dependence

Pharmacology and therapeutics of pain medications: Part 2
New CPE Series: June activity available now
USPSTF advises against vitamin D, calcium to prevent fractures in healthy adults
After its recent review, the U.S. Preventive Services Task Force (USPSTF) could not recommend vitamin D and calcium supplementation for the primary prevention of fractures in healthy adults.